Related Experiment Video
Updated: May 28, 2026
11:56
Antimicrobial Peptides Produced by Selective Pressure Incorporation of Non-canonical Amino Acids
Published on: May 4, 2018
Disruptive innovation in antibiotic development: a vision for lysins
1Department of Biotechnology, Ghent University, Ghent, Belgium.
Expert Review of Anti-Infective Therapy
|May 27, 2026
Summary
Lysins, a novel protein-based antibacterial, offer a disruptive solution to escalating antimicrobial resistance. Their targeted action and low resistance potential pave the way for precision medicine and microbiome preservation.
Area of Science:
- Microbiology
- Biotechnology
- Pharmacology
Background:
- Antimicrobial resistance (AMR) is a growing global health crisis.
- Development of new antibiotic classes has stagnated, necessitating disruptive innovation.
- Traditional antibiotics face challenges with resistance and microbiome disruption.
Purpose of the Study:
- To explore lysins as a disruptive innovation in antimicrobial therapy.
- To highlight the potential of lysins in combating AMR and preserving the microbiome.
- To discuss the integration of lysins into precision antimicrobial strategies.
Main Methods:
- Review of existing literature on lysins and antimicrobial resistance.
- Analysis of lysin characteristics, including bactericidal activity, specificity, and resistance potential.
- Exploration of protein engineering and theranostic applications of lysins.
Main Results:
- Lysins exhibit rapid, targeted bactericidal activity with low resistance potential.
- Their narrow-spectrum nature aids in microbiome preservation.
- Lysins can be engineered and combined with existing antibiotics for precision therapy.
Conclusions:
- Lysins represent a paradigm shift in antimicrobial therapy, offering a new innovation cycle.
- Their modularity and potential for synergistic effects facilitate clinical integration.
- Lysins are poised to become key components of precision antimicrobial treatments.
Related Concept Videos
01:25Inhibitors of Bacterial Protein Synthesis
Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
01:27Production of Antibiotics
Penicillin, one of the earliest and most widely used antibiotics, is produced industrially by the filamentous fungus Penicillium chrysogenum. Large stirred-tank bioreactors ranging from tens to hundreds of thousands of liters maintain tightly controlled temperature, pH, and dissolved oxygen conditions to support fungal metabolism and maximize antibiotic yield. Penicillin is a secondary metabolite, synthesized primarily during the stationary growth phase, which requires a carefully managed...
01:30Lytic Cycle of Bacteriophages
Bacteriophages, also known as phages, are specialized viruses that infect bacteria. A key characteristic of phages is their distinctive “head-tail” morphology. A phage begins the infection process (i.e., lytic cycle) by attaching to the outside of a bacterial cell. Attachment is accomplished via proteins in the phage tail that bind to specific receptor proteins on the outer surface of the bacterium. The tail injects the phage’s DNA genome into the bacterial cytoplasm. In the lytic replication...
01:23Inhibitors of Gram-positive Cell Wall Synthesis
Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
01:30Development of Antibiotic Resistance
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
01:25Clinical Significance of Antibiotic Resistance
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...